MetaCap

Avalyn Pharma Inc. (AVLN)

NASDAQ: AVLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

28.40-0.30 (-1.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AVLN stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$3.96
52-week range
22.24 – 40.17
Day range
27.85 – 29.38
Volume / Avg
214.29K / 352.95K
Beta
—

52-week range

$22.24$40.17

AVLN stock today

Avalyn Pharma (AVLN) closed at $28.40 on Nov 20, down 1.05% (-$0.30), versus the S&P 500's 3.70% decline. Shares are 29.3% below their 52-week high of $40.17, set on Aug 18, 2026 and 27.7% above the 52-week low of $22.24, in the middle of the past year's range. Avalyn Pharma has posted a net loss over the last twelve months (EPS of -$3.96), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Avalyn Pharma

Company profile

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Ms. Lyn Baranowski
Headquarters
Boston, MA
Employees
56
IPO year
2026

Analyst forecast

Forecast

Consensus (5 analysts)

strong_buy

Avg. price target

$61.00+114.79%

  • Strong buy 2
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $52.00High $80.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.67 vs $-0.64
Surprise
-4.69%

AVLN news

All AVLN news

Avalyn Pharma peers

Health Care sector
AVLN peer companies
CompanyPrice% ChgMarket capCompare
LBRXLB Pharmaceuticals Inc38.85-2.97%$1.26Bvs AVLN
INVAInnoviva Inc.18.410.00%$1.31Bvs AVLN
MNKDMannKind Corporation3.85-2.53%$1.24Bvs AVLN
SLNSilence Therapeutics Plc American Depository Share19.810.00%$1.23Bvs AVLN
GENBGenerate Biomedicines Inc.9.54-8.00%$1.23Bvs AVLN
OCULOcular Therapeutix Inc.5.57-4.95%$1.23Bvs AVLN
NUVBNuvation Bio Inc. Class A3.80-0.26%$1.34Bvs AVLN
MLYSMineralys Therapeutics Inc.13.66-3.53%$1.21Bvs AVLN

Indexes, lists and sector

Avalyn Pharma stock FAQ

What is Avalyn Pharma's stock price today?

AVLN last traded at $28.40 as of Nov 20, 4:00 PM EST, down 1.05% on the day. Prices are delayed at least 15 minutes.

Who is Avalyn Pharma's CEO?

Ms. Lyn Baranowski is the chief executive officer of Avalyn Pharma Inc., which has about 56 employees.

What is the AVLN 52-week high?

The 52-week high for AVLN is $40.17 and the 52-week low is $22.24. The stock is currently 29.3% below its high.

Compare AVLN